Janelle Schrag, MPH; Latha Shivakumar, PhD, CHCP; Monique Dawkins, EdD, MPA; Lorna Lucas, MSM; Leigh Boehmer, PharmD, BCOP
In 2019, the Association of Community Cancer Centers (ACCC) developed an immuno-oncology (IO) wallet card to address the continuous need for immune-related adverse event education and resources, particularly for IO patients and the non-oncology providers from whom they receive care. The wallet card was distributed to ACCC’s membership of cancer programs via mailings and online, which included a short survey for users to complete at time of download. Specifically, the survey included demographic questions, as well as two questions about reason for download and existing patient resources.
To better understand member needs, as well as improve IO educational resources, ACCC investigated the demographics and motivations of individuals who access the IO wallet card.
An exploratory analysis was performed on data collected through the download survey. Data included the survey responses from all downloads between March and September 2019 (n=141), which was then cleaned to remove duplicates, incomplete responses, and responses from ACCC staff, international users, pharmaceutical representatives, consultants, and patients. Analysis was then performed on the resulting data set of downloads from US-based health care providers (n=86), representing 80 unique organizations.
Support for the development of the ACCC IO wallet card and this analysis was provided by Genentech, Inc.